Search peptides, terms, sources/
Glossary

Half-Life

The time it takes for the concentration of a substance in the body to fall by half. A longer half-life generally means a substance stays active in the body for longer, which researchers use to explain a peptide’s dosing schedule within a study. Half-life on its own says nothing about a substance’s safety or effectiveness.

Peptides where this matters

  • Semaglutide

    GLP-1 receptor agonist studied in type 2 diabetes, weight management and cardiovascular outcomes. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • Tirzepatide

    Dual GIP and GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • CJC-1295CJC-1295 with DAC

    Long-acting growth-hormone-releasing hormone analogue studied for hormone levels in healthy adults. Not licensed in the UK; human evidence is small, short trials.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK

All glossary terms

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.